Literature DB >> 18634926

A Comparison of four pulpotomy techniques in primary molars: a long-term follow-up.

Deniz Sonmez1, Saziye Sari, Tuğba Cetinbaş.   

Abstract

The study evaluated the effects of formocresol (FC), ferric sulphate (FS), calcium hydroxide (Ca[OH](2)), and mineral trioxide aggregate (MTA) as pulp dressing agents in pulpotomized primary molars. Sixteen children each with at least four primary molars requiring pulpotomy were selected. Eighty selected teeth were divided into four groups and treated with one of the pulpotomy agent. The children were recalled for clinical and radiographic examination every 6 months during 2 years of follow-up. Eleven children with 56 teeth arrived for clinical and radiographic follow-up evaluation at 24 months. The follow-up evaluations revealed that the success rate was 76.9% for FC, 73.3% for FS, 46.1% for Ca(OH)(2), and 66.6% for MTA. In conclusion, Ca(OH)(2)is less appropriate for primary teeth pulpotomies than the other pulpotomy agents. FC and FS appeared to be superior to the other agents. However, there was no statistically significant difference between the groups.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18634926     DOI: 10.1016/j.joen.2008.05.009

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  40 in total

1.  Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.

Authors:  C Cuadros-Fernández; A I Lorente Rodríguez; S Sáez-Martínez; J García-Binimelis; I About; M Mercadé
Journal:  Clin Oral Investig       Date:  2015-11-18       Impact factor: 3.573

Review 2.  Evidence of pulpotomy in primary teeth comparing MTA, calcium hydroxide, ferric sulphate, and electrosurgery with formocresol.

Authors:  E Stringhini Junior; M E B Vitcel; L B Oliveira
Journal:  Eur Arch Paediatr Dent       Date:  2015-04-02

Review 3.  Mineral trioxide aggregate versus formocresol pulpotomy: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Armin Shirvani; Saeed Asgary
Journal:  Clin Oral Investig       Date:  2014-01-23       Impact factor: 3.573

4.  Direct pulp capping versus pulpotomy with MTA for carious primary molars: a randomised clinical trial.

Authors:  D Dimitraki; S N Papageorgiou; N Kotsanos
Journal:  Eur Arch Paediatr Dent       Date:  2019-02-20

5.  Five-year results of vital pulp therapy in permanent molars with irreversible pulpitis: a non-inferiority multicenter randomized clinical trial.

Authors:  Saeed Asgary; Mohammad Jafar Eghbal; Mahta Fazlyab; Alireza Akbarzadeh Baghban; Jamileh Ghoddusi
Journal:  Clin Oral Investig       Date:  2014-04-27       Impact factor: 3.573

6.  Comparison of particle morphology between commercial- and research-grade calcium hydroxide in endodontics.

Authors:  Takashi Komabayashi; Chul Ahn; Robert Spears; Qiang Zhu
Journal:  J Oral Sci       Date:  2014-09       Impact factor: 1.556

7.  Clinical Evaluation of Success of Primary Teeth Pulpotomy Using Mineral Trioxide Aggregate(®), Laser and Biodentine(TM)- an In Vivo Study.

Authors:  Krothapalli Niranjani; Madhu Ghanshyam Prasad; Aron Arun Kumar Vasa; Gaddam Divya; Mukesh Singh Thakur; Kanithi Saujanya
Journal:  J Clin Diagn Res       Date:  2015-04-01

8.  Two-year outcomes of electrosurgery and calcium-enriched mixture pulpotomy in primary teeth: a randomised clinical trial.

Authors:  F Khorakian; F Mazhari; S Asgary; M Sahebnasagh; A Alizadeh Kaseb; T Movahhed; A R Sarraf Shirazi
Journal:  Eur Arch Paediatr Dent       Date:  2014-01-17

9.  Effects of folk medicinal plant extract Ankaferd Blood Stopper(®) in vital primary molar pulpotomy.

Authors:  E Yaman; F Görken; A Pinar Erdem; E Sepet; Z Aytepe
Journal:  Eur Arch Paediatr Dent       Date:  2012-08

10.  Comparison of gray mineral trioxide aggregate and diluted formocresol in pulpotomized primary molars: a 6- to 24-month observation.

Authors:  John M Sushynski; Cameron M Zealand; Tatiana M Botero; James R Boynton; Robert F Majewski; Charles E Shelburne; Jan Chingchun Hu
Journal:  Pediatr Dent       Date:  2012 Sep-Oct       Impact factor: 1.874

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.